Literature DB >> 12880511

Rates and predictors of developing a manic or hypomanic episode 1 to 2 years following a first hospitalization for major depression with psychotic features.

Melissa P DelBello1, Gabrielle A Carlson, Mauricio Tohen, Evelyn J Bromet, Michael Schwiers, Stephen M Strakowski.   

Abstract

INTRODUCTION: Although the presence of psychosis during major depression has been identified as a predictor of later developing mania or hypomania, to our knowledge there have been no studies examining rates and predictors of developing a manic or hypomanic episode in patients who were admitted for their first psychiatric hospitalization for major depressive disorder with psychosis (MDDP).
METHODS: Patients admitted for their first psychiatric hospitalization, with a Diagnostic and Statistical Manual of Mental Disorders (fourth edition) diagnosis of MDDP, were recruited from three sites (N = 157) and evaluated prospectively for up to 2 years to identify new symptoms of mania or hypomania. Family history was assessed using the Family History-Research Diagnostic Criteria Interview. Clinical and demographic factors associated with developing a manic or hypomanic episode were identified using stepwise logistic regression.
RESULTS: Thirteen percent (n = 21) of patients with MDDP developed mania or hypomania within the follow-up period. Family history of affective disorders and age at onset of MDDP were not predictive of switch. MDDP patients who were treated with antidepressants were four times less likely to develop mania or hypomania than those who were not treated with antidepressants, after controlling for site differences.
CONCLUSIONS: Our findings suggest that within the first 1 to 2 years following first hospitalization for MDDP, a subset of patients will develop mania or hypomania. Additionally, our data suggest that antidepressant exposure does not increase the risk of, and may be protective against, developing a manic or hypomanic episode in patients hospitalized for MDDP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12880511     DOI: 10.1089/104454603322163899

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  6 in total

Review 1.  Antidepressants and psychostimulants in pediatric populations: is there an association with mania?

Authors:  Michelle Goldsmith; Manpreet Singh; Kiki Chang
Journal:  Paediatr Drugs       Date:  2011-08-01       Impact factor: 3.022

2.  Prevalence and correlates of bipolar I disorder among adults with primary youth-onset anxiety disorders.

Authors:  Benjamin I Goldstein; Anthony J Levitt
Journal:  J Affect Disord       Date:  2007-02-27       Impact factor: 4.839

3.  Early psychosocial intervention for youth at risk for bipolar I or II disorder: a one-year treatment development trial.

Authors:  David J Miklowitz; Kiki D Chang; Dawn O Taylor; Elizabeth L George; Manpreet K Singh; Christopher D Schneck; L Miriam Dickinson; Meghan E Howe; Judy Garber
Journal:  Bipolar Disord       Date:  2011-02       Impact factor: 6.744

4.  Antidepressant-coincident mania in children and adolescents treated with selective serotonin reuptake inhibitors.

Authors:  Megan F Joseph; Eric A Youngstrom; Jair C Soares
Journal:  Future Neurol       Date:  2009-01-01

5.  Ten-year outcomes in first episode psychotic major depression patients compared with schizophrenia and bipolar patients.

Authors:  M Heslin; J M Lappin; K Donoghue; B Lomas; U Reininghaus; A Onyejiaka; T Croudace; P B Jones; R M Murray; P Fearon; G A Doody; P Dazzan; T J Craig; C Morgan
Journal:  Schizophr Res       Date:  2016-05-26       Impact factor: 4.939

6.  Psychotic and affective symptoms of early-onset bipolar disorder: an observational study of patients in first manic episode.

Authors:  Lee Fu-I; Wagner de S Gurgel; Sheila C Caetano; Rodrigo Machado-Vieira; Yuan P Wang
Journal:  Braz J Psychiatry       Date:  2019-09-26       Impact factor: 2.697

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.